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Rat pituitary, hypothalamic and cerebral cortical 
minces are demonstrated to effect the conversion of 
testosterone (T) to 5~-androstan-17~-ol-3-one (DHT) and A 4- 
androstene-3,17-dione (A4A). The pituitary effected the 
greatest conversion of T to both DHT and A4A. The hypo- 
thalamus converted more T to DHT than did the cerebral 
cortex; but the conversion of T to ~4A in these two tissues 
occured to approximately the same extent. Analysis of the 
time course of the conversion of T to DHT in these tissues 
demonstrated the conversion to increase in a linear fashion 
over 180 min., while the maximum conversions in the hypo- 
thalamus and cerebral cortex were reached by 120 min. 
The conversion of T to DHT and ~4A was also demon- 
strated in the human fetal hypothalamus and pituitary, and 
in the distal femoral epiphysis of the growing rat. In the 
femoral epiphysis, 5~-androstane-3~,17~-diol was also 
identified. 
Recently, the conversion of testosterone (T) to 5~- 
androstan-17~-ol-3-one, (dihydrotesterone,DHT), a compound 
with marked androgenic activity (2), has been demonstrated 
in two target tissues of androgen action, the prostate of 
the rat and human (3-7), and in human skin (8-10). To 
assess whether this reaction might occur in other potential 
sites of androgen action, radio-labeled T was incubated 
t~84 S T E  R O I D S  14:5 
with minced preparations of mature rat hypothalami, 
pituitaries and cerebral cortices; human fetal hypothalamic 
and pituitary tissues; and the epiphyseal end of the femur 
of an immature rat. 
MATERIALS AND METHODS 
Materials. Testosterone-7~-3H, specific activity 
(SA) 1.9 Ci/mM (batch 4), obtained from Nuclear Chicago 
Co., was purified by paper chromatography (PC) in systems 
I and II (Table i). Recrystallization of an aliquot of 
this material with authentic crystalline T demonstrated 
radiochemical homogeneity. 
All organic solvents were redistilled prior to use. 
Crystalline steroid standards were recrystallized prior 
to use and melting points were determined. Chromatographic 
behavior was also assessed. 
Incubation Procedure. For the study of T metabolism 
in adult rat neural tissues, comparable weight pools of 
six pituitaries, hypothalami, and cerebral cortices were 
prepared from 59 day old male Holtzman rats and incubated 
within 30 minutes of sacrifice. The human fetal hypo- 
thalamic and pituitary tissues were obtained from a 
female fetus of i0 weeks gestational age. In all cases, 
incubations were performed within twenty minutes of 
removing the tissue. 
Tissue minces of rat pituitary, hypothalamus and 
cerebral cortex were individually prepared and incubated 
with 7.76~Ci of T-7~-3H in a calcium free Krebs-Ringer 
bicarbonate buffer, ph 7.4, without added co-factors, at 
37C for 0, 60, 120, and 180 minutes. Tissue-less control 
incubations were simultaneously performed for each time 
interval. The immature rat femoral epiphysis and human 
fetal pituitary and hypothalamic preparations were 
incubated for 90 min. under the same conditions. 
Incubations were performed in a Dubnoff metabolic incu- 
bator with 95% oxygen and 5% carbon dioxide as the gas 
phase. The average total weight of the rat pituitary 
pools used was 44 mg. (range 40-48 mg.), that of the 
hypothalamic pools was 122 mg. (range 109-138 mg.), and 
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that of the cerebral cortices was 130 mg. (range 120- 
143 mg.). The human fetal hypothalamic and pituitary 
tissues were not weighed. The reactions were terminated 
by the addition of 80~ ethanol. 
Extraction and Purification. Following the 
addition of 300 ~g of DHT and ~4-androstene-3,17-dione 
(~4A) to the pools, three extractions with 80% ethanol 
were carried out followed by two extractions with abso- 
lute ethanol. In addition, the femoral epiphyseal 
preparation was precipitated with 70% methanol at -17C 
for 48 hrs. A dichloromethane-water partition was then 
performed in a countercurrent fashion using 3 separatory 
funnels with 6 lower phase transfers. 
Chromatography. PC was performed on Whatman No. 1 
paper. All chromatography was carried out at 24 ~ 2C. 
The PC systems are listed in Table i, and will be re- 
ferred to by number. Chromatography on silica gel im- 
pregnated glass fiber sheets was performed as described 
by Payne and Mason (ii). 
TABLE 1. 
No. Solvents 
Chromatographic systems employed 

















IM NH40H (15) 
Chloroform (ii) 




3:5:5 CPC b)  
ITLC c)  
a)pc = paper chromatography 
b)CPC = column partition chromatography 
C)ITLC = glass fiber chromatography 
Estimation of Steroids. T and A4A were detected on 
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paper chromatograms by ultraviolet absorption. DHT was 
detected with alkaline m-dinitrobenze reagent (16). 
Spectrophotometric quantitation of ~4A was performed in 
ethanol at 240 m~. DHT acetate was quantitated using 
the Zimmermann reaction for 17 ketosteroids except that 
the color was developed in the dark for i0 min. and 
samples measured at 540 m~. Corrections were performed 
as described by Allen (17). Radioactive samples were 
counted in an automated 3-channel Packard Tri-Carb 
Scintillation Spectrometer (Model 3375). Each sample 
was counted in i0 ml of toluene containing 3.0 g/l PPO 
(2, 5-diphenyl-oxazole) and I00 mg/l dimethyl POPOP 
(i, 4-bis-2- (4 methyl 5-phenyl-oxazolyl) benzene) for 
sufficient time to assure a counting error no greater 
than 3%. Appropriate quench corrections were performed 
using an internal standard technique. 
Establishment of radiochemical homogeneity. Varying 
amounts of crystalline authentic steroids were added to 
each of the radioactive steroids isolated. They were 
successively recrystallized until constant SA was 
achieved. 
RESULTS 
Greater than 97% of the 3H-labeled material incubated 
was recovered following ethanol extraction. Following 
partition between dichloromethane and water, only 0.23 - 
1.6% of the starting radioactive material was found in the 
aqueous fraction. Following Celite column partition 
chromatography in system V, the bulk of this radioactive 
material in the aqueous fraction was found in the first 
holdback volume, in which unconjugated ("free") steroids 
are found, and was not analyzed further. 
All of the extracts from the dichloromethane 
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fractions were submitted to the same identification 
procedures. These fractions were submitted to PC in 
system I, and three peaks of radioactivity were noted 
with Rf values of 0.37, 0.55 and 0.66. 
The peak with an Rf of 0.37 corresponded to 
authentic T. The radioactive material in this peak 
from each tissue was subjected to PC in system II. A 
single peak of radioactivity (Rf = 0.54), corresponding 
to the mobility of authentic T, was observed. This 
radioactive material from each tissue was then separately 
acetylated (acetic anhydride: anhydrous pyridine, 1:2) 
and submitted to PC in system III. Again, a single 
peak (Rf = 0.43) with a mobility corresponding to 
authentic carrier T acetate was found in all tissues. 
Following these chromatographic procedures, aliquots 
of the T acetate-like radioactive material were taken 
for recrystallization. The SA of the first crystals 
and mother liquors were within 4% of the SA of the 
starting material. 
Following the initial PC of the radioactive material 
from the femoral epiphysis in system I, a "shoulder" in 
the testosterone-like radioactive material was observed 
in the chromatogram scan which was slightly more polar 
than T. This material was acetylated and subjected to 
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PC in system III where it ran with an Rf of 0.92. This 
material was then saponified with 2.5% Na2CO 3 and 
developed on silica gel impregnated glass fiber sheets 
in system VI. Two peaks of radioactivity were noted 
with Rf values of 0.71 and 0.77. The radioactive 
material with the Rf value of 0.77 had a mobility iden- 
tical to carrier 5~-androstane-3~-17~-diol. It was mixed 
with additional carrier and recrystallized to constant SA 
(Table 2b)° The identity of the radioactive material 
with an Rf of 0.71 could not be established. 
The radioactive material with Rf's of 0.55 and 0.66 
following the initial PC in system I corresponded to the 
mobilities of DHT and A4A respectively. The radioactive 
material from these two peaks was pooled and subjected to 
PC in system III for 18 hrs. Two peaks with mobilities 
identical to carrier DHT (Rt = 0.47) and A4A (Rt = 1.01) 
were found. The radioactive material eluted from the 
DHT-like peak was acetylated, again placed in PC in 
system III, and the chromatogram developed until the 
solvent had reached the front. In this system, authentic 
DHT acetate ran in an identical fashion to the radio- 
active material, with an Rf of 0.78. Additional 
carrier DHT acetate was added to this material and re- 
crystallization to constant SA was performed (Tables 2a 
14:5 
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and 2b). The radioactive material corresponding to ~4A 
was submitted to PC in system IV, and developed until 
the solvent had reached the front. Again, radio- 
activity and carrier A4A traveled in an identical 
fashion. Additional authentic crystalline ~4A was added 
and recrystallization to constant SA effected (Tables 2a 
and 2b). 
As can be seen in Fig i, of the rat neural tissues 
studied, the pituitary effected the conversion of T to 
DHT to the greatest extent (26.2 x 10 -7 ~moles/mg). This 
conversion increased in a linear fashion over the time 
range studied. The hypothalamus was also capable of 
effecting this conversion, but to a lesser extent than 
the pituitary (9.01 x 10 -7 !lmoles/mg). In the hypo- 
thalamus, the reaction appeared to reach a maximum by 
120 minutes, and then fall slightly. Cerebral cortical 
tissue also possessed 5~-reducing capacity, but as can 
be seen in Fig i, to a lesser extent than in either of 
the two other tissues (3.54 x 10 -7 ~moles/mg). No DHT 
was found in the tissue-less control incubations. 
In addition to DHT, as can be seen in Fig 2, ~4A 
was also found in all three neural tissues. Again, the 
pituitary had the greatest 176 dehydrogenase enzymatic 
capacity (3.82 x 10 -7 llmoles/mg). However, there was 
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no appreciable difference between hypothalamic and 
cortical activity in regard to this enzymatic function 
(1.47 x 10 -7 and 1.43 x 10 -7 ~moles/mg respectively). 
Small quantities of A4A (0.i0 - 0.17%) were found in 
the control flasks. These values have been subtracted 
from the corresponding tissue incubation values. 
As can be seen in Table 2b, both DHT and A4A were 
also formed in the human fetal pituitary and hypo- 
thalamus, and in the distal femoral epiphysis of the 
growing rat. In the human fetal hypothalamus, DHT and 
A4A were formed in approximately equal amounts. 
fetal pituitary, more A4A than DHT was formed. In the 
femoral epiphysis, approximately equal amounts of DHT 
and A4A were found (DHT, 309 dpm/mg; A4A, 368 dpm/mg). 
In the 
Discussion 
The data presented herein demonstrate that T can be 
converted to DHT and A4A in the mature rat pituitary, 
hypothalamus and cerebral cortex, as well as in the hypo- 
thalamus and pituitary of the human fetus and the distal 
femoral epiphysis of the growing rat. The use of 
viable mince preparations of these tissues rather 
than homogenates obviated the need for co-factors. 
In the rat brain tissues studied, the greatest 
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conversion both to DHT and A4A, per mg of tissue, 
occured in the pituitary gland. DHT was formed to a 
greater extent in the hypothalamus than in the cerebral 
cortex, while A4A was formed in approximately the same 
amounts in both of the latter tissues. A linear increase 
in the formation of DHT was observed in the pituitary 
tissues during the 180 minutes studied. It is possible 
that these conversions are related to the degree of T 
uptake by these tissues (18). 
Uptake of T in both pituitary and hypothalamus 
following infusion of this compound to the adult rat as 
observed recently by Whalen et al. (19) and Samperez 
et al. (18) plus the present finding that these tissues 
can convert T to DHT, suggests the possibility that DHT 
may play a role, either by itself or in conjunction with 
in the regulation of pituitary luteinizing hormone. To 
evaluate this postulate, the comparative effects of T and 
DHT on the suppression of radioimmunoassayable LH in the 
rat (20) are being evaluated currently. 
The finding of DHT and A4A demonstrates the presence 
of both 5~ reductase and 17~ dehydrogenase enzymes in 
these tissues. In other studies on steroid hormone 
metabolism in brain tissue, Sholiton et al. (21) found 
that the rat brain was capable of oxidizing or reducing 
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cortisol and cortisone. Grosser and Axelrod (22) 
found that tissue from various areas of the brains of 
fetal, newborn and adult baboons also converted cortisol 
to cortisone. They also found cortisol and cortisone 
acetate in the fetal and newborn brain. Although 
steroid acetates were sought in the presently described 
experiments, none was found. Knapstein et al. (23) 
demonstrated the sulfurylation of dehydroepiandrosterone 
in the human fetal brain. In the present experiments, 
steroid sulfates, including T sulfate, were sought but 
not found. The binding and retention of DHT in rat 
prostate have been demonstrated to occur in the nuclei 
(3,7). It remains to be ascertained whether, in neural 
tissues, the reaction is also intranuclear. 
Upon intravenous administration of tritiated 
testosterone to normal rats, DHT was identified in 
prostate, seminal vesicle and preputial gland, all 
presumed targets of androgen action. In contrast, no 
DHT was found in liver, heart, lungs, testes, or levator 
ani muscle, although, with the exception of the levator 
ani, there was 3 to 9 times as much radioactivity in 
the latter tissues as in those in which DHT was found (3). 
The finding of the conversion of T to DHT in 
14:5 
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human fetal hypothalamic and pituitary tissues is of 
particular interest since we (25) and others (26,27) 
have demonstrated the capacity of the human fetal testes 
to biosynthesize T and because of the recent finding of 
gonadotropins in human fetal pituitaries (28). 
Since androgens are also known to exert action on 
the epiphyseal ends of long bones in growing mammals, 
the conversion of T to DHT and 5~-androstane-3~,17~- 
diol (which also has significant androgenic activity (2)) 
in the femoral epiphysis is of interest. Our findings 
of 17~ dehydrogenase and 5~ reductase activity in the 
growing rat are in contrast to those of Murota and 
Tamaoki, who studied both progesterone and T metab- 
olism in the epiphyses of femora and tibiae from 13 
day old chick embryos and found 3~-hydroxy, 5~ reduced 
metabolites (29). It is possible that the type of 
reduction varies with the species involved. 
Whether the in vitro conversions demonstrated herein 
also occur in vivo remains to be ascertained. Current 
investigations in this laboratory are being directed 
toward this question, as well as the subcellular site 
of the reactions. 
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Fig. i. 
Fig. 2. 
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Conversion of testosterone to androstan-17B-ol- 
3-one by adult rat brain tissues. Incubations 
at each time interval were performed on a pool 
of tissue obtained from six animals. 
D P M / m g  
2 5 0 0  I I I I I 
2 0 0 0  - 
1500 - O -  ' 
P ITUITARY 
IO00 / HYPOTHALAMUS  oo/ 
b -- ,~ CORTEX 
L,-- i 1"- I I I 
50 60  90  120 150 180 
M I N U T E S  
Conversion of testosterone to A 4 androstene-3, 
17-dione by adult rat brain tissues. 

























O -~  
O -~ 































co ~") rg ~", 
;.-I I.~ co cg 
~D'~ LO L~ ug ug 
~ ~ U U  
~ ~ o  ~ 
o ~ ~  ~ 
~ ~ o  ~ ~  ~ ~  
o ~ o ~  ~ ~  ~ o o ~  




1.4 ,-.t ,--I 
4J . ~  ~ 







I ° °  
-,-4 
,-.-I 
• ~ ~-t 
~ O 
II II I I  
rd ,£I 0 


























































~ o ~  ~ ~  o ~ ~  
r~ .~ 
4~ 4z 
:~ 0 -,~ 
l:l:l 
, - I  ,--I r~ 
..I.a 
~ O ~ ~  
~ o ~  ~ ~  ~ ~  
~ o ~ o  ~ ~  ~ ~  
) 
m u u N m D D N  m U U N 
Nov.  1969 S T E R O I D S 497 
ACKNOWLEDGMENTS 
The expert technical assistance of Mrs. Ulla Lindholm 
in all phases of this study is very gratefully acknowledged. 
We are indebted to Dr. Vernon L. Gay for obtaining the 













Portions of this investigation were presented at the 
Fifty-First Meeting of The Endocrine Society, 
New York, June 27, 1969. 
Dorfman, R.I. and Shipley, R.A., Androgens. Biochemis- 
try, Physiology and Clinical Significance. John Wiley 
and Sons, Inc., New York, 1956, p. 118. 
Bruchovsky, N. and Wilson, J.D., J. Biol. Chem. 
243: 2012, 1968. 
Bruchovsky, N. and Wilson, J.D., J. Biol. Chem. 
243: 5953, 1968. 
Shimazaki, J., Kurihara, H., Yoshikazu, I. and 
Shida, K., Gunma J. Med. Sci., 14: 313, 1965. 
Shimazaki, J., Kurihara, H., Ito, Y. and Shida, K., 
Gunma J. Med. Sci., 14: 326, 1965. 
Anderson, K.M. and Liao, S., Nature, 219: 277, 1968. 
Wilson, J.D. and Walker, J.D., J. Clin. Invest., 
48: 371, 1969. 
Mauvais-Jarvis, P., Bercovici, J.P. and Gauthier, 
F., J. Clin. Endocr. 29: 417, 1969. 
Northcutt, R.C., Island, D.P. and Liddle, G.W., 
J° Clin. Endocr. 29: 422, 1969. 
Payne, A.H. and Mason, M., Anal, Biochem. 2_66: 460, 
1968. 
















S T E R O I D S  
Neher, R., In Engel. L.L. (ed.), Physical Properties 
of the Steroid Hormones, MacMillan Co., New York, 
1963, p. 65. 
Savard, K., Recent Progr. Hormone Res. ~: 185, 1954. 
Siiteri, P.K., Vande Wiele, R.L., and Lieberman, S., 
J. Clin. Endocr. 20: 588, 1963. 
Savard, K., J. Biol. Chem. 202: 457, 1953. 
Allen, W.M., J. Clin. Endocr. i0: 71, 1950. 
Samperez, S., Thieulant, M.L., Poupon, R., 
Duval, J. and Jovan, P., Bull. Soc. Chem. Biol. 
(Paris), 51: 117, 1969. 
Whalen, R.E., Luttge, W.G. and Green, R., 
Endocrinology, 8_~4: 217, 1969. 
Gay, V.L., Rebar, R.W. and Midgley, A.R., Jr., 
Proc. Soc. Exp. Biol. Med., 130: 1344, 1969. 
Sholiton, L.J., Werk, E.E., Jr., and Mac Gee, J., 
Metabolism, 14: 122, 1965. 
Grosser, B.I. and Axelrod, L.R., Steroids, ll: 
829, 1968. 
Knapstein, P., David, A., Wu, C-H, Archer, D.F., 
Flickinger, G.L. and Touchstone, J.C., Steroids 
ii: 885, 1968. 
Pear 1 man, W.H. and Pearlman, M.R.J., J. Biol. 
Chem. 236: 1321, 1961. 
f ° 
Serra, G.B., Perez-Palaclos, G. and Jaffe, R.B., 
Unpublished data. 
Acevedo, H.F., Axelrod, L.R., Ishikano, E. and 
Takak, F., J. Clin. Endocr. 23: 885, 1963. 




Kaplan, S.L., Grumbach, M.M. and Shepard, T.H., 
Abstracts, Soc. Ped. Res. p. 8, May 2, 1969. 
Murota, S.I. and Tamaoki, B.-I., Biochem. Biophys. 
Acta, 137: 347, 1967. 
